 |
|
New Oral Anticoagulants versus Warfarin for Cerebral Venous Thrombosis: A Multi-Center, Observational Study
Mohammad Wasay, Maria Khan, Haris Majid Rajput, Salman Farooq, Mohammed Ibrahim Memon, Suhail Abdulla AlRukn, Abdul Malik, Foad Abd-Allah, Raja Farhat Shoaib, Rizwana Shahid, Sadia Nishat, Safia Awan
J Stroke. 2019;21(2):220-223. Published online 2019 May 31 DOI: https://doi.org/10.5853/jos.2019.00150
|
|
Citations to this article as recorded by
 Cerebral Venous Thrombosis: Medical Management vs. Endovascular Therapy
Sabrina L. Begley, Timothy G. White, Jeffrey M. Katz
Current Treatment Options in Neurology.2023; 25(6): 169. CrossRef Safety and efficacy of Direct Oral Anticoagulants in cerebral venous thrombosis: A meta‐analysis
Gaurav Nepal, Sanjeev Kharel, Riwaj Bhagat, Yow Ka Shing, Megan Ariel Coghlan, Prasanta Poudyal, Rajeev Ojha, Gentle Sunder Shrestha
Acta Neurologica Scandinavica.2022; 145(1): 10. CrossRef Cavernous Sinus Thrombosis and Blindness Complicating Dental Infection
Emily Ming Choo Ng, Othmaliza Othman, Li Yen Chan, Nor Akmal Bahari
Cureus.2022;[Epub] CrossRef Cerebral venous thrombosis
D.R. Safina, R.G. Esin, A.A. Khakimova, L.R. Alimbekova
Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova.2022; 122(3): 11. CrossRef Efficacy and safety of the direct oral anti‐coagulants in patients with cerebral vein thrombosis: A systematic review and meta‐analysis
Nicoletta Riva, Francesca Galea, Isaac Buhagiar, Alex Gatt, Jean Calleja‐Agius
British Journal of Haematology.2022; 198(1): 165. CrossRef Cerebral venous sinus thrombosis as the initial presentation of essential thrombocythemia - A case report and literature review
Qudsum Yousaf, Haseeb Amad Khan, Fateen Ata, Adeel Ahmad Khan, Nadia Karim, Zohaib Yousaf
eNeurologicalSci.2022; 27: 100398. CrossRef
Addendum to guidelines on the investigation and management of venous thrombosis at unusual sites (
Br. J. Haematol
. 2012;159:28–38): Use of Direct Oral Anticoagulants
Renu Riat, Keith Gomez
British Journal of Haematology.2022; 198(1): 46. CrossRef Vision Preservation in COVID-Related Cerebral Sinovenous Thrombosis With Optic Nerve Sheath Fenestration
Andrew B. Johnston, Asim F. Choudhri, Violiza Inoa, Lauren C. Ditta
Journal of Neuro-Ophthalmology.2022; 42(2): e463. CrossRef Warfarin versus factor Xa inhibitors in the long-term treatment of cerebral venous sinus thrombosis a single-center retrospective analysis
Alexei Christodoulides, Bradley N. Bohnstedt
eNeurologicalSci.2022; 28: 100412. CrossRef Long-Delayed Manifestation of COVID-19 Coagulopathy Presenting with Severe Cerebral Venous Thrombosis Causes Massive Brain Hemorrhage
Mardjono Tjahjadi, Sinatrya Caropeboka, Christian Permana, Krisandi Susanto, Eka Susanto
Asian Journal of Neurosurgery.2022; 17(02): 342. CrossRef Direct Oral Anticoagulants Versus Vitamin K Antagonists in Cerebral Venous Thrombosis: A Systematic Review and Meta-Analysis
Shadi Yaghi, Ian J. Saldanha, Chelsea Misquith, Bashar Zaidat, Asghar Shah, Kareem Joudi, Bianca Persaud, Feras Abdul Khalek, Liqi Shu, Adam de Havenon, Eva A. Mistry, Ekaterina Bakradze, Eric D. Goldstein, John Reagan, Aikaterini Theodorou, Lina Palaiodi
Stroke.2022; 53(10): 3014. CrossRef Patient-guided modifications of oral anticoagulant drug intake during Ramadan fasting: a multicenter cross-sectional study
AbdulAziz Batarfi, Haitham Alenezi, Abdulrahman Alshehri, Saud Balelah, Hameedullah Kazim, Mohammed Algthami, Mariam M. Hussain, Nada Alshehri, Rahaf Alsharif, Hadeel Ashour, Mutaz Althobaiti, Shomokh Alotaibi, Helmuth Steinmetz, Christian Foerch
Journal of Thrombosis and Thrombolysis.2021; 51(2): 485. CrossRef Direct oral anticoagulants for unusual‐site venous thromboembolism
Nicoletta Riva, Walter Ageno
Research and Practice in Thrombosis and Haemostasis.2021; 5(2): 265. CrossRef Rivaroxaban for the treatment of cerebral venous thrombosis
Sara Esmaeili, Meysam Abolmaali, Sobhan Aarabi, Mohammad Reza Motamed, Samira Chaibakhsh, Mohammad Taghi Joghataei, Mohammad Mojtahed, Zahra Mirzaasgari
BMC Neurology.2021;[Epub] CrossRef Direct oral anticoagulants in treatment of cerebral venous thrombosis: a systematic review
Gauruv Bose, Justin Graveline, Vignan Yogendrakumar, Risa Shorr, Dean A Fergusson, Gregoire Le Gal, Jonathan Coutinho, Marcelo Mendonça, Miguel Viana-Baptista, Simon Nagel, Dar Dowlatshahi
BMJ Open.2021; 11(2): e040212. CrossRef Internal Jugular Vein Thrombosis: Etiology, Symptomatology, Diagnosis and Current Treatment
Alba Scerrati, Erica Menegatti, Matilde Zamboni, Anna Maria Malagoni, Mirko Tessari, Roberto Galeotti, Paolo Zamboni
Diagnostics.2021; 11(2): 378. CrossRef Ischemic Stroke in the Young
Samuel A. Berkman, Shlee S. Song
Clinical and Applied Thrombosis/Hemostasis.2021; 27: 107602962110022. CrossRef Cerebral venous thrombosis and its hemorrhagic complications
A. A. Kulesh
Neurology, Neuropsychiatry, Psychosomatics.2021; 13(2): 10. CrossRef Impact of anticoagulation status on recanalization and outcome of cerebral venous thrombosis
Ashish K. Dubey, Jayantee Kalita, Sarvesh K. Chaudhary, Usha K. Misra
Journal of Clinical Neuroscience.2021; 89: 43. CrossRef Neurocritical Care of the Pregnant Patient
Deepa Malaiyandi, Elysia James, Lindsay Peglar, Nurose Karim, Nicholas Henkel, Kristin Guilliams
Current Treatment Options in Neurology.2021;[Epub] CrossRef Cerebral Venous Thrombosis Caused by Spontaneous Intracranial Hypotension: A Case Report
Kyung-Jae Lee, Sung-Tae Kim, Won-Hee Lee, Keun Soo Lee, Sung Hwa Paeng, Se-young Pyo
Korean Journal of Neurotrauma.2021; 17(2): 174. CrossRef The Novel Oral Anticoagulants (NOACs) for the Treatment of Cerebral Venous Thrombosis: A Case Study of 32 Vietnamese Patients
Thang H. Nguyen, Triet M. Ngo, Bau V. Phan, Binh N. Pham, Nha T. T. Dao, An T. T. Nguyen, Trung Q. Nguyen, Hoang T. Phan
Journal of Stroke Medicine.2021; 4(2): 105. CrossRef Evidence-Based Minireview: Should warfarin or a direct oral anticoagulant be used in patients presenting with thrombosis in the splanchnic or cerebral veins?
Carol Mathew, Marc Zumberg
Hematology.2021; 2021(1): 100. CrossRef Cerebral and Splanchnic Vein Thrombosis: Advances, Challenges, and Unanswered Questions
Nicoletta Riva, Walter Ageno
Journal of Clinical Medicine.2020; 9(3): 743. CrossRef Comparing the efficacy and safety of direct oral anticoagulants with vitamin K antagonist in cerebral venous thrombosis
Grace K. H. Lee, Vanessa H. Chen, Choon-Han Tan, Aloysius S. T. Leow, Wan-Yee Kong, Ching-Hui Sia, Nicholas W. S. Chew, Tian-Ming Tu, Bernard P. L. Chan, Leonard L. L. Yeo, Vijay K. Sharma, Benjamin Y. Q. Tan
Journal of Thrombosis and Thrombolysis.2020; 50(3): 724. CrossRef Preliminary findings regarding the use of direct oral anticoagulants in cerebral venous thrombosis
Andrew Hsu, Hetal Mistry, Nupur Lala, John L. Reagan
Clinical Neurology and Neurosurgery.2020; 198: 106204. CrossRef Anticoagulation in splanchnic and cerebral vein thrombosis: An international vignette‐based survey
Nicoletta Riva, Marc Carrier, Alex Gatt, Walter Ageno
Research and Practice in Thrombosis and Haemostasis.2020; 4(7): 1192. CrossRef Comparison of Novel Oral Anticoagulants and Vitamin K Antagonists in Patients With Cerebral Venous Sinus Thrombosis on Efficacy and Safety: A Systematic Review
Hongjie Li, Meiling Yao, Songjie Liao, Jingyan Chen, Jian Yu
Frontiers in Neurology.2020;[Epub] CrossRef Non-Vitamin K Antagonist Oral Anticoagulants in Medical Conditions at High Risk of Thromboembolism beyond Atrial Fibrillation
Keun-Sik Hong
Journal of Stroke.2019; 21(3): 259. CrossRef Cortical venous thrombosis – A case series and review of recent updates
Shivangi Garg, Dinesh Chaudhari, PushpendraNath Renjen, Kamal Ahmad, Abhas Kumar, Rajendra Pradhan, Anjali Mishra
Apollo Medicine.2019; 16(4): 232. CrossRef
|